Atopic dermatitis (AD) is a very common, heterogeneous and debilitating disease with a need for new treatment options CAN10 ...

Children with atopic dermatitis are more likely to develop uveitis than children without it, especially if the dermatitis is severe.

When Mariam Kacheche gave birth to her son, she noticed that his skin was much lighter than she had expected. But she didn't ...

Discover a recent study that compared a new emulsion versus petrolatum for treating paediatric eczema. Learn more.

The representation of Black and Asian adults is on the rise in atopic dermatitis clinical trials, according to a study. As ...

Aclaris Therapeutics, Inc.’s ACRS share price has surged by 6.72%, which has investors questioning if this is right time to sell.

On Tuesday morning, Galderma launched its Scratch Resistance campaign to highlight one of the most difficult symptoms of atopic dermatitis: nonstop itching. The campaign’s ad spot features atopic ...

Complete BiomX Inc. stock information by Barron's. View real-time PHGE stock price and news, along with industry-best analysis.

BiomX Inc. company and executive profile by Barron's. View the latest PHGE company infomation and executive bios.

Dermatology providers reported strong impacts on the work and home life of patients with moderate to severe chronic hand eczema, a manifestation of atopic dermatitis.

Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.

A research team at Korea University Medical School discovered a gene-regulating substance called 'miR-4497', which was ...